title: Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation.
authors.forename: E
authors.initials: E
authors.lastname: Rumi
authors.forename: F
authors.initials: F
authors.lastname: Passamonti
authors.forename: L
authors.initials: L
authors.lastname: Arcaini
authors.forename: P
authors.initials: P
authors.lastname: Bernasconi
authors.forename: C
authors.initials: C
authors.lastname: Elena
authors.forename: D
authors.initials: D
authors.lastname: Pietra
authors.forename: A
authors.initials: A
authors.lastname: Brisci
authors.forename: E
authors.initials: E
authors.lastname: Arbustini
authors.forename: M
authors.initials: M
authors.lastname: Cazzola
authors.forename: M
authors.initials: M
authors.lastname: Lazzarino
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D018365:Neoplasm, Residual / Q000235:genetics; D055728:Primary Myelofibrosis / Q000235:genetics / Q000628:therapy*; D053628:Receptors, Thrombopoietin / Q000235:genetics; D013920:Thrombocythemia, Essential / Q000235:genetics / Q000628:therapy*; D018183:Transplantation Chimera; D014184:Transplantation, Homologous
chemical_list: D053628:Receptors, Thrombopoietin; C082218:MPL protein, human